Ligelizumab treatment for severe asthma: learnings from the clinical development programme.
Trischler J, Bottoli I, Janocha R, Heusser C, Jaumont X, Lowe P, Gautier A, Pethe A, Woessner R, Zerwes HG, Zielen S.
Trischler J, et al. Among authors: pethe a.
Clin Transl Immunology. 2021 Mar 15;10(3):e1255. doi: 10.1002/cti2.1255. eCollection 2021.
Clin Transl Immunology. 2021.
PMID: 33747510
Free PMC article.